N-terminal proBNP levels in patients with Chagas disease: A marker of systolic and diastolic dysfunction of the left ventricle

European Journal of Echocardiography

Volumn 8, Issue 3, 2007, Pages 204-212

  Barbosa, Marcia M ^a   Nunes, Maria do Carmo P ^a,b   Ribeiro, Antônio Luiz P ^b   Barral, Marselha M ^a,b   Rocha, Manoel Otávio C ^b  

^a Hospital Geral Socor   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chagas disease; Doppler echocardiography; Heart failure; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIASTOLIC HEART FAILURE; DISEASE MARKER; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RADIOLOGICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; SYSTOLIC HEART FAILURE;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CHAGAS DISEASE; DIASTOLE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; STROKE VOLUME; SYSTOLE; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34247480366     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1016/j.euje.2006.03.011     Document Type: Article

References (36)

1. Groenning B.A., Nilsson J.C., Sondergaard L., Pedersen F., Trawinski J., Brumann M., et al. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J 143 (2002) 923-929
2. Cheung B.M.Y., and Kumana C.R. Natriuretic peptides: relevance in cardiac disease. JAMA 280 (1998) 1983-1984
3. Maeda K., Takayoshi T., Wada A., Hisangaga T., and Knoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135 (1998) 825-832
4. Yoshimura M., Yasue H., Okamura K., Ogawa H., Jougasaki M., Mukoyama M., et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with CHF. Circulation 87 (1993) 464-469
5. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.L., and Burnett Jr. J.C. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction. Circulation 109 (2004) 3176-3181
6. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., and Kazanegra R. Utility of natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings. Circulation 105 (2002) 595-601
7. Vinch C.S., Aurigemma G.P., Hill J.C., Gaasch W.H., Volturo G., Tighe D.A., et al. Usefulness of clinical variables, echocardiography and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure. Am J Cardiol 91 (2003) 1140-1143
8. Pozzoli M., Traversi E., Cioffi G., Stenner R., Sanarico M., and Tavazzi K. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation 95 (1997) 1222-1230
9. Whalley G.A., Doughty R.N., Gamble G.D., Wright S.P., Walsh H.J., Muncaster S.A., et al. Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure. J Am Coll Cardiol 39 (2002) 1787-1795
10. Faris R., Coats A.J.S., and Henein M.Y. Echocardiography-derived variables predict outcome in patients with nonischemic dilated cardiomyopathy with or without a restrictive filling pattern. Am Heart J 144 (2002) 343-350
11. Ribeiro A.L.P., Reis A.M., Barros M.V.L., Sousa M.R., Rocha A.L.L., Perez A.A., et al. Brain natriuretic peptide and left ventricular dysfunction in Chagas disease. Lancet 360 (2002) 461-462
12. Ribeiro A.L., Reis A.M., Teixeira M.M., and Rocha M.O. Brain natriuretic peptide in Chagas disease: further insights. Lancet 362 (2003) 333
13. Talvani A., Rocha M.O., Cogan J., Maewal P., de Lemos J., Ribeiro A.L.P., et al. Brain natriuretic peptide and left ventricular dysfunction in human chagasic cardiomyopathy. Mem Inst Oswaldo Cruz 99 6 (2004) 645-649
14. Yeo K.T., Allan H.B., Apple F.S., Knoll M.H., Christenson R.H., Lewandrowski, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 338 1-2 (2003 Dec) 107-115
15. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. A Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
16. Ren J.F., Kotler M.N., DePace N.L., Mintz G.S., Kimbiris D., Kalman P., et al. Two-dimensional echocardiographic determination of left atrial emptying volume: a noninvasive index in quantifying the degree of nonrheumatic mitral regurgitation. J Am Coll Cardiol 2 (1983) 729-736
17. Rokowski H., Appleton C., Chan K.L., Dumesnil J.G., Honos G., Jue J., et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 9 (1996) 736-760
18. Garcia M.J., Thomas J.D., Asher C., Rodriguez L., and Vandervoort P. A index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. J Am Coll Cardiol 29 (1997) 448-454
19. Nishimura R.A., and Tajik A.J. Evaluation of diastolic filling of the left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 30 (1997) 8-18
20. Oh J.K., Appleton C.P., Hatle L.K., Nishimura R.A., Seward J.B., and Tajik A.J. The non-invasive assessment of the left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 10 (1997) 246-270
21. Maisel A.S., McCord J., Nowak R.M., Hollander J.E., Wu A.H.B., Duc P., et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: results from the Breathing Not Properly (BNP) multinational study. J Am Coll Cardiol 41 (2003) 2010-2017
22. Massie B.M. Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure. J Am Coll Cardiol 41 (2003) 2018-2021
23. Dokainish H., Zoghbi W.A., Lakkis N.M., Al-Bakshy F., Dhir M., Quinones M.A., et al. Optimal noninvasive assessment of left ventricular filling pressures. A comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 109 (2004) 2432-2439
24. Barros M.V.L., Machado F.S., Ribeiro A.L.P., and Rocha M.O.C. Diastolic function in Chagas disease: an echo and tissue Doppler imaging study. Eur J Echo 5 (2004) 182-188
25. Dokainish H., Zoghbi W.A., Lakkis N.M., Quinones M.A., and Nagueh S.F. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol 93 (2004) 1130-1135
26. Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., and Seward J.B. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90 (2002) 1284-1289
27. Werner G.S., Schaefer C., Dirks R., Figulla H.R., and Kreuzer K. Prognostic value of Doppler echocardiographic assessment of left ventricular filling dilated cardiomyopathy. Am J Cardiol 73 (1994) 792-798
28. Rihal C.S., Nishimura R.A., Hatle L.K., Bailey K.R., and Tajik A.J. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation 90 (1994) 2772-2779
29. Xie G.Y., Martin R.B., Smith M.D., Gurley J.C., and DeMaria A.N. Prognostic value of Doppler transmitral flow in patients with congestive heart failure. J Am Coll Cardiol 24 (1994) 132-139
30. Pinamonti B., Zecchin M., Di Lenarda A., Gregori D., Sinagra G., and Camerini F. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol 29 (1997) 604-612
31. Nunes MCP. Estudo de marcadores prognósticos clínicos e Doppler ecocardiográficos em pacientes com miocardiopatia dilatada chagásica. Doctoral thesis. Faculdade de Medicina, UFMG.
32. Mayer A.S., De Lemos J.A., Murphy A.S., Brooks S., Roberts E., and Grayburn P.A. Comparison of B-type natriuretic peptide levels in patients with heart failure with mitral regurgitation vs. those without mitral regurgitation. Am J Cardiol 93 (2004) 1002-1006
33. Loke I., Squire I.B., Davies J.E., and Ng L.L. References range for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur Heart Fail 5 (2003) 599-606
34. Logeart D., Saudubray C., Beyne P., Thabut G., Ennezat P.V., Chavelas C., et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 40 (2002) 1794-1800
35. Nishimura R., Appleton C., Redfield M., Ilstrup D., Holmes D., and Tajik A. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 28 (1996) 1226-1233
36. Yamamoto K., Nishimura R.A., Chaliki H.P., Appleton C.P., Holmes Jr. D.R., and Redfield M.M. Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery disease: critical role of left ventricular systolic function. J Am Coll Cardiol 30 (1997) 1819-1826